Eli Lilly advances CRISPR collaboration with Scribe Therapeutics for neurological and neuromuscular disorders; European ...
One year after receiving CRISPR gene editing therapy at CHOP, a Delaware County baby is thriving, and doctors want to expand ...
A caffeine-triggered switch that turns CRISPR gene editing on and off inside cells could one day improve cancer therapy.
Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time fix for high cholesterol.
Scientists at Texas A&M are turning an everyday pick-me-up into a high-tech medical switch. By combining caffeine with CRISPR ...
February 25, 2026 marks one year since KJ, an infant born with severe carbamoyl phosphate synthetase 1 (CPS1) deficiency, became the world's first person to receive a personalized CRISPR-based gene ...
Intellia Therapeutics (NasdaqGM:NTLA) has completed enrollment in its phase 3 HAELO trial of lonvo-z for hereditary angioedema. The FDA has lifted the clinical hold on Intellia’s MAGNITUDE-2 trial for ...
For years, treating gum disease has meant scraping away plaque, cutting out damaged tissue or turning to antibiotics that ...
Researchers at Vilnius University (Lithuania) have uncovered how the bacterial protein Cas9, better known as the CRISPR-Cas ...
A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving ...
A research group led by Associate Professor Tetsuya Muramoto from the Faculty of Science, Toho University, has established a CRISPR genome editing technique that enables comparative analysis of the ...
How innovative technologies like AI and gene editing are advancing rare disease drug discovery and development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results